Complement Factor H Mutation in Familial Thrombotic Thrombocytopenic Purpura with ADAMTS13 Deficiency and Renal Involvement

Marina Noris; Sara Bucchioni; Miriam Galbusera; Roberta Donadelli; Elena Bresin; Federica Castelletti; Jessica Caprioli; Simona Brioschi; Friedrich Scheiflinger; Giuseppe Remuzzi

doi:10.1681/asn.2005010086

Abstract

1 min read

Thrombotic thrombocytopenic purpura is a rare disorder of small vessels that is associated with deficiency of the von Willebrand factor-cleaving protease ADAMTS13, which favors platelet adhesion and aggregation in the microcirculation. The disease manifests mainly with central nervous system symptoms, but cases of renal insufficiency have been reported. Presented are findings of the genetic basis of phenotype heterogeneity in thrombotic thrombocytopenic purpura in two sisters within one family. The patients had ADAMTS13 deficiency as a result of two heterozygous mutations (causing V88M and G1239V changes). In addition, a heterozygous mutation (causing an S890I change) in factor H of complement was found in the patient who developed chronic renal failure but not in her sister, who presented with exclusive neurologic symptoms.

Related publications

Article2006

In-vitro and in-vivo consequences of mutations in the von Willebrand factor cleaving protease ADAMTS13 in thrombotic thrombocytopenic purpura

Roberta Donadelli, Federica Banterla, Miriam Galbusera, Cristina Capoferri, Sara Bucchioni, Sara Gastoldi, Silvia Nosari, Giuseppe Monteferrante, Zaverio M. Ruggeri, Elena Bresin, Friedrich Scheiflinger, Edoardo Rossi, Constantino Martı́nez, Rosanna Coppo, Giuseppe Remuzzi, Marina Noris

Article2004

Diverse Functional Implications of ADAMTS13 Gene Mutations in Patients with TTP and Congenital Deficiency.

Roberta Donadelli, Federica Banterla, Cristina Capoferri, Miriam Galbusera, Zaverio M. Ruggeri, Sara Bucchioni, Marina Noris, Giuseppe Remuzzi

Article2009

Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies

Sara Gastoldi, Erica Daina, Daniela Belotti, Enrico Pogliani, Paolo Perseghin, Potito Rosario Scalzulli, Rossella Paolini, R Marcenò, Giuseppe Remuzzi, Miriam Galbusera, Elena Bresin

Article2002

von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome

Giuseppe Remuzzi, Miriam Galbusera, Marina Noris, Maria Teresa Canciani, Erica Daina, Elena Bresin, Silvia Contaretti, Jessica Caprioli, Sara Gamba, Piero Ruggenenti, Norberto Perico, Pier Mannuccio Mannucci

Article1998

von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome

Miha Furlan, Rodolfo Robles, Miriam Galbusera, Giuseppe Remuzzi, Paul A. Kyrle, B. Brenner, Manuela Krause, I. Scharrer, V. Aumann, U. Mittler, Max Solenthaler, Bernhard Lämmle